ADAPTIMMUNE THERAPEUTICS PLC
NASDAQ: ADAP (Adaptimmune Therapeutics plc)
Kemas kini terakhir: 6 jam lalu0.136
-0.01 (-9.67%)
| Penutupan Terdahulu | 0.150 |
| Buka | 0.142 |
| Jumlah Dagangan | 56,824,261 |
| Purata Dagangan (3B) | 73,990,428 |
| Modal Pasaran | 35,914,492 |
| Harga / Jualan (P/S) | 0.510 |
| Harga / Buku (P/B) | 2.68 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 12 Nov 2025 |
| Margin Keuntungan | -38.91% |
| Margin Operasi (TTM) | -604.96% |
| EPS Cair (TTM) | -0.300 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 28.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 626.29% |
| Nisbah Semasa (MRQ) | 2.02 |
| Aliran Tunai Operasi (OCF TTM) | -107.85 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -30.50 M |
| Pulangan Atas Aset (ROA TTM) | -14.19% |
| Pulangan Atas Ekuiti (ROE TTM) | -275.74% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Adaptimmune Therapeutics plc | Bercampur | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.0 |
| Purata | 0.63 |
|
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 0.63% |
| % Dimiliki oleh Institusi | 44.16% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |